Home > Boards > US OTC > Medical - Drugs >

Elite Pharmaceuticals (ELTP)

ELTP RSS Feed
Add ELTP Price Alert      Hide Sticky   Hide Intro
Moderator: Drugdoctor, dr_lowenstein, NASDAQ2020, IB_, namtae, Chasing
Search This Board: 
Last Post: 3/21/2019 1:25:06 PM - Followers: 857 - Board type: Free - Posts Today: 40

Elite Pharmaceuticals, Inc. (ELTP)

\
\
Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company developing a pipeline of proprietary pharmacological abuse-deterrent opioid products and niche generic products. Elite specializes in oral sustained and controlled release drug products with high barriers to entry. Elite owns generic which have been licensed to TAGI Pharma, Epic Pharma, Dr. Reddy’s Laboratories and Glenmark Pharmaceuticals Inc., USA.

Elite currently has eight commercial products currently being sold, six products filed with the FDA, additional approved products pending manufacturing site transfer and the NDA filing for SequestOx™.

Elite’s pipeline products include abuse-deterrent opioids utilizing the Company’s patented proprietary technology and a once-daily opioid. These products include sustained release oral formulations of opioids for the treatment of chronic pain. These formulations are intended to address two major limitations of existing oral opioids: the provision of consistent relief of baseline pain levels and deterrence of potential opioid abuse.


Located in Northvale, New Jersey, Elite operates a 55,000 square foot campus under Current Good Manufacturing Practice (“cGMP”) and is a United States Drug Enforcement Agency (“DEA”) registered facility for research, development, manufacturing and packaging of pharmaceutical products.
 

About Elite's Abuse Deterrent Technology

Elite's abuse deterrent products utilize the Company's proprietary pharmacological abuse deterrent technology. Elite's abuse deterrent technology is a multi-particulate capsule which contains an opioid agonist in addition to naltrexone, an opioid antagonist. Naltrexone is an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence. When this product is taken as intended, the naltrexone is designed to pass through the body unreleased while the opioid agonist releases over time providing therapeutic pain relief for which it is prescribed. If the multi-particulate beads are crushed, the opioid antagonist, naltrexone, is designed to release. The absorption of the naltrexone is intended to block the euphoria by preferentially binding to same receptors in the brain as the opioid agonist and thereby reducing the incentive for abuse or misuse by recreational drug abusers.
\
 
Elite continues to expands the intellectual property for the Company's opioid abuse deterrent technology. Elite now has four US patents, one European patent, and two Canadian patents issued in this area with additional patents pending in the U.S., Canada and Europe.

More information including Elite’s proprietary Abuse Resistant Technology can be found at http://www.elitepharma.com
 

Products & Pipeline
 
Screen%20Shot%202017-05-28%20at%2011.53.29%20AM.png
 
Elite’s principle product is SequestOx™,  an immediate-release oxycodone with sequestered naltrexone abuse-deterrent opioid product for the management of moderate to severe acute pain. Additional products include bariatric, cardiovascular, antihistamine, skeletal muscle relaxants, antipsychotic, tricyclic antidepressant, along with a number of approved products pending manufacturing site transfer.
 
Elite owns generic and OTC products which have been licensed to TAGI Pharma, Epic Pharma, Dr. Reddy's Laboratories and Valeant Pharmaceuticals International. Additional information regarding Elite’s wholly owned products, partnerships, and contract manufacturing can be found at  http://www.elitepharma.com/products
\
\
\The list of pipeline products can be found at http://www.elitepharma.com/pipeline-generics
 
Leadership
 
Nasrat Hakim, Chairman, President & Chief Executive Officer
 
Nasrat Hakim joined Elite in August 2013 as Director, President and Chief Executive Officer. Mr. Hakim has more than 30 years of pharmaceutical and medical industry experience in Quality Assurance, Analytical Research and Development, Technical Services and Regulatory Compliance. He brings with him proven management experience, in-depth knowledge of manufacturing systems, development knowledge in immediate and extended release formulations and extensive regulatory experience of GMP and FDA regulations. Prior to his leading Elite, from 2004 to 2013, Mr. Hakim was employed by Actavis, Watson and Alpharma in various senior management positions. Most recently, Mr. Hakim served as International Vice President of Quality Assurance at Actavis, overseeing 25 sites with more than 3,000 employees under his leadership.  Mr. Hakim also served as Corporate Vice President of Technical Services, Quality and Regulatory Compliance for Actavis U.S., Global Vice President, Quality and Regulatory Compliance for Alpharma, as well as Executive Director of Quality Unit at TheraTech, overseeing manufacturing and research and development. In 2009, Mr. Hakim founded Mikah Pharma, LLC, a virtual, fully functional pharmaceutical company. 

Mr. Hakim’s career started in Medical Laboratory Technology from the Academy of Health and Sciences in the U.S. Army based in San Antonio, TX, followed by Graduate Certification in Regulatory Affairs (RAC) from California State University at Sacramento, Sacramento, CA; Bachelor in Chemistry/Bio-Chemistry and Masters of Science in Chemistry from California State University at Sacramento, Sacramento, CA; and a Masters in Law with Graduate Certification in U.S. Taxation from St. Thomas University, School of Law, Miami, FL.
 

Investor Relations and Corporate Inquiries

Dianne Will
Vice President of Investor Relations and Corporate Affairs
Telephone: 518-398-6222
Email: 
dianne@elitepharma.com

Corporate Headquarters
165 Ludlow Avenue
Northvale, New Jersey 07647
Phone: 201-750-2646
Fax: 201-750-2755


 

Miscellaneous Links:
 
Elite Pharmaceuticals News
http://ir.elitepharma.com/press_releases
 
SEC Filings
http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001053369&owner=include

FDA website
http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails

Clinical Trials.Gov
https://www.clinicaltrials.gov/
 
Yahoo Finance
https://finance.yahoo.com/quote/ELTP/?p=ELTP
 
Seeking Alpha
https://seekingalpha.com/symbol/ELTP
 

_ELTP Daily Chart_
    


ELTP
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ELTP News: Current Report Filing (8-k) 03/11/2019 04:04:21 PM
ELTP News: Current Report Filing (8-k) 02/12/2019 06:11:04 AM
ELTP News: Current Report Filing (8-k) 01/03/2019 03:58:43 PM
ELTP News: Current Report Filing (8-k) 12/10/2018 04:02:19 PM
ELTP News: Current Report Filing (8-k) 11/20/2018 04:08:02 PM
PlusOneCoin Top Posts
#311241   Recent Top 10 Pieces of BS Against ELTP JustGoDeep 03/07/19 11:13:29 AM
#307989  Restored 274770 is Still Garbage Information JustGoDeep 01/15/19 10:00:31 PM
#310826  Restored Uhhh…this has already been explained. reaper247 03/02/19 01:03:23 AM
PostSubject
#311210  Sticky Note 2019: Elites 2019 Monster LineUp NASDAQ2020 03/06/19 10:42:08 PM
#309422  Sticky Note Conference Call Transcript February 12, 2019 Chasing 02/12/19 06:46:40 PM
#306366  Sticky Note WOWSERS-$ELTP now has 41 DRUG PRODUCTS on FDA-National-Drug-Code-WEBSITE! Drugdoctor 12/14/18 07:14:49 PM
#303967  Sticky Note Wishfull thinking , elite will need another 100 Dr_Thorfin 11/19/18 08:43:48 AM
#302013  Sticky Note "Within 12 months, stock will be at $1 IB_ 10/17/18 06:44:01 PM
#274770  Sticky Note memorable "calls" for elite pharma: dr_lowenstein 10/24/17 04:09:11 PM
#185967  Sticky Note The only topic here is ELTP. IH Dan (Retired) 02/23/16 09:32:46 PM
#312270   Insider selling might be marker for why both namtae 03/21/19 01:38:14 PM
#312269   People around the world come here for WeeZuhl 03/21/19 01:25:06 PM
#312268   J GO D...Wezul posting is speaking only from SCHH 03/21/19 01:03:56 PM
#312267   Show proof. mrwrn2010 03/21/19 01:03:19 PM
#312266   Must be why many Americans seek healthcare beyond jour_trader 03/21/19 01:00:52 PM
#312265   Meanwhile the World Comes to America for Healthcare JustGoDeep 03/21/19 12:45:12 PM
#312264   Well said. imanjen13 03/21/19 12:31:33 PM
#312263   Looking at last years form 4 filing, it imanjen13 03/21/19 12:27:01 PM
#312262   we have the best healthcare for the patient WeeZuhl 03/21/19 12:21:40 PM
#312261   Elite/SunGen 2 this Friday or maybe Monday!!!!!!!! ARbigguy1 03/21/19 12:08:02 PM
#312260   $405 MILLION market available to Elite for current ARbigguy1 03/21/19 12:07:10 PM
#312258   Daily Market Maker Manipulation is Amusing JustGoDeep 03/21/19 11:08:47 AM
#312256   Interesting Markets UP across the board namtae 03/21/19 10:24:25 AM
#312255   Regulations are NOT that strict because this administration SCHH 03/21/19 10:21:29 AM
#312254   That buyer is probably buying Elites SVP shares, namtae 03/21/19 10:18:38 AM
#312253   67,500 bought at .098 THAT IS SCHH 03/21/19 10:14:17 AM
#312252   More like it is highly unlikely Elite gets Jimmy Joe 03/21/19 10:13:45 AM
#312251   Agreed! Just should have intent to do so when filing namtae 03/21/19 10:10:51 AM
#312250   $50,000-Dollars is Significant??? It is Pocket Change, YIKES!! JustGoDeep 03/21/19 10:10:14 AM
#312249   Elites SVP filing 144 to DUMP almost 500,000 shares namtae 03/21/19 10:07:52 AM
#312248   Contradicts from what NASDAQ posted yesterday: Q. When is jour_trader 03/21/19 10:07:26 AM
#312247   Until you have a legitimate link of the YJ4LIFE 03/21/19 10:05:34 AM
#312246   see Nasdaq's post about QA on the form 144 PH4RM4C3UT1C4LS 03/21/19 10:04:54 AM
#312245   "A person filing a Form 144 must have PH4RM4C3UT1C4LS 03/21/19 10:04:10 AM
#312244   it merely advises that the party is seeking Jimmy Joe 03/21/19 10:03:27 AM
#312243   Sorry but the SVP filing 144 with the namtae 03/21/19 10:01:25 AM
#312242   Why would anyone drive to a cul de Jimmy Joe 03/21/19 10:00:57 AM
#312241   Must went to the wrong building. The parking YJ4LIFE 03/21/19 09:51:10 AM
#312240   All possible reasons. My understanding of the filing imanjen13 03/21/19 09:47:40 AM
#312239   I was there an hour ago and the Hutch321 03/21/19 09:44:11 AM
#312237   Within 90 days, you say? PH4RM4C3UT1C4LS 03/21/19 09:27:19 AM
#312235   Drove by Elites parking lot 2 hours ago... EMPTY!! namtae 03/21/19 08:59:13 AM
#312234   Good Morning Elite Profit 03/21/19 06:50:27 AM
#312233   It's 640 am and all the equipment at newguy11 03/21/19 06:43:54 AM
#312232   Sure, I dont think that is correct dr_lowenstein 03/21/19 01:41:05 AM
#312231   Never did it before so how could they mrwrn2010 03/21/19 12:42:20 AM
#312230   Doesn't add up. Jimmy Joe 03/20/19 11:19:18 PM
#312229   I didnt think about that, do you think dr_lowenstein 03/20/19 10:56:35 PM
#312228   Who will make the drug cheaper? I'm betting Jimmy Joe 03/20/19 10:49:57 PM
#312227   Cue the “but what if Elite is selling mrwrn2010 03/20/19 10:06:41 PM
#312226   Rule 144 of the Securities Act of 1933, NASDAQ2020 03/20/19 08:56:21 PM
#312225   Solid move back up today. Profit 03/20/19 08:49:01 PM
#312223   In this case, it would only be filed jour_trader 03/20/19 08:36:44 PM
#312222   Total B.S. This guy isn't considered a control person namtae 03/20/19 08:32:53 PM
#312220   No toofun 03/20/19 08:08:40 PM
#312218   Thx for sharing NASDAQ2020 03/20/19 07:53:13 PM
#312214   There is NO SEC FORM 144 reporting service! ARbigguy1 03/20/19 07:37:13 PM
#312213   All about perception management. jour_trader 03/20/19 07:35:09 PM
#312211   What a freaking joke..... aELmTPa 03/20/19 07:31:11 PM
#312209   The Form is 144. It permits him to imanjen13 03/20/19 07:26:58 PM
PostSubject